United Therapeutics Corporation (UTHR) Institutional Ownership & Insider Trading

877 institutions reported holding United Therapeutics Corporation shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 2,866 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

UTHRUnited Therapeutics CorporationFollow UTHR — free

Drug Manufacturers - Specialty & Generic · Healthcare

—

Price chart with a free account

Market cap: 25.2B
P/E TTM: 21.0
Dividend yield: —
52-week: —
Next earnings: 4 Nov, in 11 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

877 institutions held 97.4% of the shares. Across filers that reported both quarters, shares held changed -0.9%.

Largest moves, shares (millions)

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters

Quarter	Holders	Shares held, M	Change	Increased	New	Decreased	Closed
Jun 26	877	42	-0.9%	281	86	303	56
Mar 26	845	41	-0.2%	268	85	301	67
Dec 25	815	42	+0.6%	253	137	229	47
Sep 25	688	41	-5.2%	182	90	253	52
Jun 25	661	44	-2.0%	252	58	200	58
Mar 25	656	44	+1.3%	216	59	198	68
Dec 24	657	44	-0.2%	237	58	180	33
Sep 24	609	43	-8.2%	181	87	203	37

United Therapeutics Corporation — questions

Who owns United Therapeutics Corporation stock?: 877 institutions reported United Therapeutics Corporation shares in 13F filings for the quarter ended 2026-06-30. The largest: BlackRock, Inc. (12.3%), Avoro Capital Advisors LLC (6.5%), VANGUARD PORTFOLIO MANAGEMENT LLC (4.5%).
Are United Therapeutics Corporation insiders buying or selling?: 2,866 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from United Therapeutics Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.